You can buy or sell Opiant and other stocks, options, ETFs, and crypto commission-free!
Opiant Pharmaceuticals, Inc. Common Stock, also called Opiant, is a biopharmaceutical company, which develops pharmaceutical solutions for common addictions and related disorders. Read More The company focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Santa Monica, CA.
Santa Monica, California
52 Week High
52 Week Low
Stock Price, News, & Analysis for Opiant Pharmaceuticals
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops pharmacological treatments for substance use, addictive and eating disorders. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes treatments for eating disorders, including bulimia nervosa and binge eating disorders, alcohol use disorders, a long term treatment to prevent relapse for patients with opioid use disorders, cocaine use disorders, and a heroin vaccine....
Available Mar 21, After Hours